• Nie Znaleziono Wyników

Effects of diabetes and vascular occlusionon adenosine-induced relaxant response of ratcommon carotid artery

N/A
N/A
Protected

Academic year: 2022

Share "Effects of diabetes and vascular occlusionon adenosine-induced relaxant response of ratcommon carotid artery"

Copied!
10
0
0

Pełen tekst

(1)

Effects of diabetes and vascular occlusion on adenosine-induced relaxant response of rat common carotid artery

Miroslav Radenkoviæ1, Marko Stojanoviæ1, Radmila Jankoviæ2, Mirko Topaloviæ1, Milica Stojiljkoviæ1

1Department of Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Belgrade, PO Box 38, 11129 Belgrade, Serbia

2Institute of Pathology, Faculty of Medicine, University of Belgrade, Dr. Subotica 1, 11000 Belgrade, Serbia Correspondence: Miroslav Radenkoviæ, e-mail: miroslavr@beotel.net

Abstract:

Background: The aim of this study was to investigate effect of adenosine on isolated rat common carotid artery (CA) submitted to occlusion in non-diabetic or diabetic animals, and to determine whether endothelium denudation or potassium conductance block af- fects adenosine action.

Methods: Experiments were conducted on Wistar rat CA with or without endothelium. Diabetes was induced by alloxan. Occlusion of CA was performed in randomly selected non-diabetic or diabetic animals anesthetized with urethane. Thus, experiments were per- formed in four groups of rats: non-operated (control) animals without or with diabetes and operated animals submitted to the occlu- sion of CA without or with diabetes. Concentration-response curves for adenosine were obtained in a cumulative fashion on precontracted arteries.

Results: Adenosine produced concentration-dependent and endothelium-independent relaxation of CA with comparable maximal effects in all groups. Analysis of pEC50values showed that responsiveness of CA decreased in following order: [diabetes (–) / occlu- sion (–)] = [diabetes (–) / occlusion (+)] > [diabetes (+) / occlusion (–)] > [diabetes (+) / occlusion (+)]. In the presence of high K+ maximal relaxant response of CA from non-operated rats without diabetes was reduced. The recorded inhibition was even stronger in animals subjected to CA occlusion. Conversely, in non-operated diabetic animals obtained reduction of adenosine effect was less pronounced in regard to non-diabetic rats.

Conclusions: Adenosine produced equi-effective endothelium-independent relaxation of CA in all groups. Pharmacological po- tency of adenosine was reduced in diabetic animals solely, but even more in diabetic rats submitted to CA occlusion. The enhanced potassium transmembrane flow has certain protective role on adenosine-induced action in occluded CA from non-diabetic rats. Con- versely, diabetes solely inhibited adenosine-evoked cascade connected to increased potassium conductance.

Key words:

adenosine, common carotid artery, occlusion, diabetes, endothelium, potassium channels

(2)

Introduction

Adenosine is an ubiquitous purine nucleoside and it is a product of complete dephosphorylation of adenine nucleotides catalyzed by the membrane or intracellu- lar 5’-nucleotidases. This nucleoside has a wide dis- tribution in almost every tissue and it is an important signal molecule engaged in transduction mechanisms regarding the modulation of many physiological pro- cesses [32]. Accordingly, it can be assumed that the main role of adenosine is to maintain homeostasis, and it is involved in key biochemical processes [35].

In physiological conditions, the concentration of adenosine in various body fluids and tissues is low.

However, in different pathological conditions under- lined by tissue ischemia or anoxia, the concentration of adenosine rapidly increases, which is a protective tissue response [24].

Adenosine actions are related to the activation of adenosine receptors that belong to a well defined group of G protein-coupled receptors [39]. Among adenosine receptors, four types have already been dis- tinguished: A1, A2A, A2B, and A3 [5]. So far, it has been established that vasodilatations in response to adenosine are mainly due to the direct activation of adenosine receptors located on vascular smooth mus- cle cells [4, 18, 29]. However, in other blood vessels adenosine induces indirect action after activation of adenosine receptors located on endothelial cells and secondary release of different endothelial relaxing factors [2, 12, 38]. After the activation of specific adenosine receptor, the further signaling pathway would typically involve an opening of specific potas- sium channels or activation of Na+/K+-ATPase on the vascular smooth muscle cell [29]. Namely, increased potassium channel conductance hyperpolarizes smooth muscle and thereby reduces smooth muscle contrac- tion via reduced calcium entry through the voltage- dependent calcium channels [13]. This all underlines the importance of increased potassium conductance as a notable part in adenosine-induced vascular effects.

It is known that the carotid artery supplies cerebral blood flow from the systemic circulation, suggesting that this artery participates as an important regulator of cerebral circulation [20]. Likewise, there is a nota- ble degree of evidence that adenosine contributes to the overall cerebral blood flow during physiological and different pathological conditions [26]. Accord- ingly, it has been for example shown that transient in- tracarotid infusion of adenosine increases cerebral

blood flow and decreases cerebrovascular resistance without affecting intracranial pressure or evoking ad- verse systemic hemodynamic side effects, which led to an assumption that intracarotid adenosine might be useful for evaluation of intraarterial vasodilator ther- apy and for controlled manipulation of cerebrovascu- lar resistance [16]. It is also known that adenosine can be released from carotid bodies in response to hy- poxia, thus contributing to the carotid body chemore- ceptor sensitivity [6]. Still, the underlying mechanism of the vasodilatory effect of adenosine in carotid ar- teries from different species is under investigation.

Moreover, limited data are available considering pos- sible changes in transduction mechanism of adenosine action in this blood vessel regarding the vascular oc- clusion or diabetes, especially regarding up-to-date knowledge that vascular responsiveness and the func- tional features of different blood vessels are altered in diabetes mellitus. This is also in accordance to the fact that relation between diabetic micro- and macro- angiopathy and endothelial dysfunction is complex and it is still a subject of extensive research [41].

Taking into account previous considerations, this study was undertaken in order to investigate an effect of adenosine on isolated rat common carotid artery submitted to occlusion in non-diabetic or diabetic ani- mals, and to determine the effects of endothelial denu- dation or potassium conductance block on adenosine action in investigated blood vessel.

Materials and Methods

The standards from the European Convention for the Protection of Vertebrate Animals Used for Experi- mental and other Scientific Purposes, as well as guidelines from the Good Laboratory Practice were fully applied in regard to procedures with used ani- mals [3]. The methodology described in this article was in accordance with our previous investigations [29, 30, 33, 34] and was approved by the Ethical Commission for the Welfare Protection of Experi- mental Animals (Medical Faculty, University of Bel- grade, 2010 – 1500/05).

Our experiments involved male Wistar rats that were two months old and 220–250 g of weight at the beginning of the study. The experimental design in- cluded two groups of rats – the first group without

Adenosine action on carotid artery in diabetes

Miroslav Radenkoviæ et al.

(3)

diabetes, and the second group with alloxan-induced diabetes. Each group was further divided into three clusters: non-operated, sham-operated and operated rats. Experimental diabetes was induced in randomly selected animals with single intraperitoneal injection of 150 mg/kg alloxan dissolved in normal saline [21, 40]. Blood sample for glucose estimation was col- lected every seven days from rat tail vein [7]. Only the rats with glucose higher than 11 mM after four weeks were included in the study [27]. Thus, the ani- mals with short-lasting diabetes of 4 weeks and their age-matched controls were used for further experi- ments. In the group of operated rats, the left and the right common carotid artery were occluded for 45 min by cords [33]. Those animals were previously sub- jected to anesthesia conducted with single intraperito- neal application of 1.25 g/kg urethane [22]. After the induction of anesthesia, the rats were placed on a heated table and fitted with a tracheal cannula to fa- cilitate spontaneous breathing. Animals were allowed to stabilize for a period of 90 min before carotid artery occlusion. The same protocol was conducted in the group of sham-operated rats, except of the carotid ar- tery occlusion procedure.

Common carotid artery was carefully isolated from rat, dissected from surrounding fat and connective tis- sue, cut into circular segments (which were 4 mm long) and immediately placed in Krebs-Ringer bicarbonate solution (composition in mM: NaCl 118.3; KCl 4.7;

CaCl2 2.5; MgSO4 1.2; KH2PO4 1.2; NaHCO3 25.0;

Ca-EDTA 0.026; glucose 11.1). The endothelium was

removed from some rings by gently rubbing the inti- mal surface with stainless-steel wire. Vascular rings were mounted between two stainless-steel triangles in an organ bath containing Krebs-Ringer bicarbonate solution (37°C, pH 7.4) and aerated with 95% O2and 5% CO2. One of the triangles was attached to a dis- placement unit allowing a fine adjustment of tension, and further connected to a force-displacement trans- ducer (Hugo Sachs Elektronik F30 Type 372, Frei- burg, Germany). Isometric tension was continuously recorded on a Rikadenki R-62 multi-pen electronic re- corder (Rikadenki Kogyo Co., Ltd, Tokyo, Japan).

At the beginning of each experiment, endothelium functional integrity was examined by precontraction of isolated carotid artery with submaximal concentra- tion (EC50–EC70) of serotonin, followed by the addi- tion of acetylcholine (1 µM). This procedure was re- peated three times in 20 min intervals (Fig. 1). Re- laxation > 80% of serotonin precontraction was indicative for the functionally intact endothelium. The morphological integrity of vascular endothelium was additionally confirmed at the end of randomly se- lected experiments by preparing histological prepara- tions of rat carotid artery with standard hematoxylin and eosin stain. Concentration-response curves for adenosine were obtained in a cumulative fashion on serotonin-precontracted arteries. Since separate ex- periments in preparations of carotid artery demon- strated that the first and the second concentration- response curve (determined 45 min apart) for adeno- sine were not significantly different (Fig. 1), a multi-

demonstrated that the first and the second concentration-response curve (determined 45 min apart) for adeno- sine were not significantly different.

ACh = acetylcholine; 5-HT = serotonin

(4)

ple curve design protocol was applied for the experi- ments with high K+. Oppositely, in experiments with denuded arteries only one concentration-response curve was obtained on rings with or without endothe- lium, but always from the same rat.

The effect induced by each concentration of adeno- sine was expressed as a relaxation percentage of serotonin-produced precontraction. The results were expressed as the means ± SEM and n refers to the number of experiments. The concentration of adeno- sine producing 50% of its own maximum response (EC50) was determined by using a non-linear least square fitting procedure of the individual experimen- tal data, and was presented as pEC50 (pEC50 = –log EC50). All calculations were done by using the com- puter program Graph Pad Prism (Graph Pad Software Inc., San Diego, USA). Statistical significance of dif- ferences between two means was determined with the Student’s t-test. A value of p < 0.05 was considered to be statistically significant.

The following chemicals were used: adenosine, al- loxan, urethane (Sigma-Aldrich, St Louis, MO, USA);

acetylcholine iodide (Serva, Heidelberg, Germany);

serotonin (ICN, Irvine, CA, USA). All agents were

dissolved in distilled water and diluted to the desired concentration with the buffer. During experimental procedure all agents were added directly to the organ bath in a volume of 150 µl and the concentrations given are the calculated final concentrations in the bath solution.

Results

Adenosine (0.01–100 µM) produced comparable concentration-dependent relaxation of carotid arteries obtained from non-operated (max. % relaxation

= 97.0 ± 5.8; pEC50= 5.94 ± 0.22) and sham-operated (max. % relaxation = 99.4 ± 2.3; pEC50= 5.13 ± 0.25) rats without induced diabetes. Equivalent result was recorded after endothelial denudation (non-operated rats: max. % relaxation = 108.4 ± 3.8; pEC50 = 5.64

± 0.26 and sham-operated rats: max. % relaxation = 98.5 ± 2.0; pEC50= 5.58 ± 0.24). In addition, similar findings were obtained in diabetic rats (data not shown). Taking into account that we did not detect any significant difference between adenosine-induced

Adenosine action on carotid artery in diabetes

Miroslav Radenkoviæ et al.

Fig. 2. Adenosine-induced relaxation in isolated rat common carotid artery after the endothelial denudation. Vas- cular rings have been obtained from non-diabetic (A, B) and diabetic (C, D) animals. The vascular occlusion was additionally performed on randomly selected non-diabetic (B) or diabetic (D) rats. Each point represents the mean ± SEM (n = 4–7). Vascular re- laxations induced by adenosine are expressed as percentages of the pre- contraction induced by serotonin

(5)

action in non-operated and sham-operated rats, and also in order to avoid further unnecessary use of ex- perimental animals in accordance to “The 3Rs” prin- ciple [9, 25, 28], from this point the control group consisted only of non-operated rats.

The adenosine-induced maximal relaxant response of rings with or without endothelium was similar in all investigated groups, indicating an equi-effective ac- tion of adenosine irrespective of diabetes or vascular occlusion (Fig. 2, Tab. 1, p > 0.05). Likewise, the analysis of the median effective concentrations (pEC50) showed that the response of intact or denuded vessels to adenosine was comparable within each group, thus confirming an endothelium-independent relaxation (Fig. 2, Tab. 1, p > 0.05). In accordance, the histologi-

cal evaluation did not show any evidence of morpho- logical differences in preparations obtained from non-operated animals without (Fig. 3A,B) or with (Fig. 3C,D) diabetes, which suggests the preservation of vascular endothelial and smooth muscle cells after short-term diabetes. Similar finding was observed in other investigated groups (pictures not shown).

The calculated median effective concentrations gradually decreased in-between investigated groups in the following order: [diabetes (–) / occlusion (–)] = [diabetes (–) / occlusion (+)] > [diabetes (+) / occlu- sion (–)] > [diabetes (+) / occlusion (+)], which actu- ally corresponds to the progressive decrease in adeno- sine pharmacological potency. Although it was found that diabetes solely reduced the responsiveness of ca-

Diabetes (–) Diabetes (+)

Occlusion (–) Occlusion (+) Occlusion (–) Occlusion (+)

Max. % relaxation

pEC50 Max. % relaxation

pEC50 Max. % relaxation

pEC50 Max. % relaxation

pEC50

Endothelium (+) 97.0 ± 5.8 5.94 ± 0.22 99.7 ± 2.1 5.77 ± 0.27 94.7 ± 3.2 5.13 ± 0.23 100.1 ± 5.9 4.59 ± 0.34 Endothelium (–) 108.4 ± 3.8 5.64 ± 0.26 95.2 ± 3.2 5.45 ± 0.25 95.3 ± 1.8 4.91 ± 0.27 104.1 ± 4.1 4.85 ± 0.29

A B

C D

E ( + ) E ( - )

E ( + ) E ( - )

Fig. 3. Histological preparations of in- tact and denuded rat common carotid arteries obtained from non-diabetic (A, B) and diabetic (C, D) animals that were not subjected to the vascular oc- clusion (hematoxylin and eosin stain, magnification = 400´; E = endothe- lium)

(6)

rotid artery to adenosine, the most prominent differ- ence was noted between non-operated rats without diabetes and the group of diabetic animals addition- ally subjected to the carotid artery occlusion (Tab. 1, p < 0.05). This was also accompanied with the match- ing rightward shift of cumulative concentration-res- ponse curves for adenosine on intact or endothelium denuded rings, which is separately presented in Fig- ure 4A,B.

Although our statistical evaluation indicated that adenosine induced endothelium-independent relaxa- tion within each group, it was also of interest to exam- ine if short term diabetes or transient vascular occlu- sion independently influenced an endothelial input in the effect of investigated purine nucleoside. Thus, in endothelium-free preparations from non-operated dia- betic animals, the concentration-response curve for adenosine was notably shifted to the right if compared to endothelium-intact rings from non-operated and diabetes-free rats (Fig. 4C, Tab. 1, p < 0.01). In agree- ment with previous statistical analysis considering diabetes, the similar, yet less pronounced trend was detected in regard to the separate influence of tran-

sient vascular occlusion on the involvement of endo- thelial cells in adenosine relaxant action (Fig. 4D, Tab. 1, p < 0.05).

In the presence of high K+(100 mM), maximal re- laxant response of carotid arteries obtained from both non-operated and operated rats without diabetes was significantly reduced (Fig. 5A,B, Tab. 2, p < 0.01).

Still, the recorded inhibition of adenosine-induced relaxation in diabetes-free rats was more evident in animals subjected to the occlusion than in non- operated rats (max % relaxation in the presence of high K+: 15.8 ± 9.5 vs. 31.2 ± 11.3, respectively, Tab. 2, p < 0.05). On the other hand, in non-operated diabetic animals the obtained reduction of adenosine- induced effect was also apparent (p < 0.05), yet if compared to the corresponding group without diabe- tes this inhibition was notably less pronounced (Fig.

5C; Tab. 2; p < 0.01). Interestingly, in the group of diabetic animals subjected to the carotid artery occlu- sion, adenosine-induced relaxation in the presence of high K+was reduced at the same extent as in arteries obtained from non-operated rats without diabetes (Fig. 5D, Tab. 2).

Adenosine action on carotid artery in diabetes

Miroslav Radenkoviæ et al.

Fig. 4. The effect of concomitant pres- ence of diabetes and vascular occlu- sion on action induced by adenosine on endothelium-intact (A) or endothe- lium-denuded vascular rings (B), and the comparison of individual input of diabetes (C) or vascular occlusion (D) to the contribution of intact endothe- lium in adenosine-induced vascular relaxation. Each point represents the mean ± SEM (n = 4–7). Vascular re- laxations induced by adenosine are expressed as percentages of the pre- contraction induced by serotonin

(7)

Discussion

In the present study, adenosine produced concentra- tion-dependent relaxation with comparable maximal relaxant response in all investigated groups. There- fore, we can assume that short-term diabetes and/or transient vascular occlusion did not affect overall pharmacological efficacy of investigated purine nu- cleoside. This is also in accordance with the per-

formed histological evaluation suggesting the mor- phological preservation of endothelial and smooth muscle cells in physiological or investigated patho- logical conditions.

In our previous investigations on isolated rat aorta, inferior mesenteric or femoral artery we have reported that adenosine induced concentration-dependent re- laxation, which was unaffected by endothelial denu- dation [11, 29, 31]. Accordingly, in the present study, it also appears that intact endothelium does not have

(A, B) and diabetic (C, D) animals. The vascular occlusion was additionally performed on randomly selected non- diabetic (B) or diabetic (D) rats. Each point represents the mean ± SEM (n = 5–7). Vascular relaxations induced by adenosine are expressed as percent- ages of the precontraction induced by serotonin. * p < 0.05 and ** p < 0.01 compared to the control relaxant effect

Tab. 2. Adenosine-induced relaxation in isolated rat common carotid artery in the presence of hyperpolarizing solution (KCl = 100 mM).

The concentration of adenosine eliciting 50% of its own maximum response (EC50) is presented as pEC50(pEC50= –log EC50), whereas maxi- mal obtained relaxation is expressed as a percentage of the precontraction produced by serotonin. Each result represents the mean ± SEM (n = 5–7; E = endothelium)

Diabetes (–) Diabetes (+)

Occlusion (–) Occlusion (+) Occlusion (–) Occlusion (+)

Max. % relaxation

pEC50 Max. % relaxation

pEC50 Max. % relaxation

pEC50 Max. % relaxation

pEC50

Control, E (+) 92.1 ± 10.1 5.86 ± 0.27 97.7 ± 2.0 5.82 ± 0.25 98.4 ± 2.9 5.37 ± 0.25 102.8 ± 2.8 4.77 ± 0.31 KCl, 100 mM 31.2 ± 11.3 4.78 ± 0.11 15.8 ± 9.5 4.33 ± 0.16 70.9 ± 12.5 5.14 ± 0.34 32.1 ± 11.9 4.79 ± 0.36

(8)

significant role in the carotid artery response to adenosine in any of investigated groups of rats. This for the most part excludes the established impact of diabetes-induced functional changes on endothelial cells that were consequently related to the altered pharmacological action of various endogenous va- sorelaxant agonists in experiments on rats [1, 8, 37, 42, 43]. From our findings it can be also suggested that the carotid artery relaxation was most probably initiated by activation of specific adenosine binding sites located solely on smooth muscle cells irrespec- tive of diabetes or vascular occlusion.

Although the evaluation of relaxant responses to the highest adenosine concentration did not demon- strate significant difference in-between investigated groups, an additional analysis of the calculated me- dian effective concentrations was performed. The finding that the vascular occlusion in the group of non-diabetic animals did not change adenosine- induced relaxation on rings with or without endothe- lium would exclude any significant alterations regard- ing the pharmacological potency of adenosine con- nected to the applied transient procedure on the ca- rotid artery. This is also indicative for the assumption that vascular occlusion most probably did not affect transduction mechanism of adenosine-evoked effect on the level of vascular smooth muscle cells.

On the other hand, the presence of diabetes solely led to a notable reduction in the blood vessel respon- siveness to adenosine if compared to non-diabetic ani- mals, which clearly indicates probable changes at the level of adenosine binding sites on smooth muscle cells or further intracellular signalling mechanisms.

Still, the most pronounced increase in the median ef- fective concentration was obtained in the group of diabetic rats concomitantly submitted to the carotid artery occlusion. This was accompanied with corre- sponding rightward shift of the cumulative concentra- tion-response curves for adenosine. Therefore, it ap- pears that in pathological setting of experimental dia- betes, the short-term ischemia of investigated blood vessel additionally contributed to the decreased vas- cular responsiveness to adenosine. In other words, taking into account that the median effective concen- tration as a pharmacological term corresponds to the potency of investigated drug [23], it can be also pro- posed that the potency of adenosine action was sig- nificantly inhibited by functional changes at the level of smooth muscle cells induced concurrently by dia- betes and vascular occlusion.

As previously mentioned, the analysis of endothe- lium input in carotid artery response was performed within each group, thus suggesting an endothelium- independent mechanism. However, if one would com- pare concentration-response curve and corresponding median effective concentration obtained in endothe- lium-intact rings from non-operated and diabetic-free rats with one acquired in endothelium-denuded prepa- rations from diabetic rats, it could be proposed the presence of endothelium-dependent relaxation in dia- betic versus healthy animals. The same assumption could be put forward for non-diabetic animals submit- ted to vascular occlusion opposed to non-diabetic and non-operated animals. Still, since we consistently ob- tained endothelium-independent relaxation within each group of investigated animals, further experiments are necessary to confirm, at this point speculative hypothe- sis, that the short-term diabetes or transient occlusion can actually stimulate an endothelium-dependent, thus most probably protective mechanism in adenosine- evoked relaxations of isolated rat carotid artery.

In the second part of our study, it was of interest to investigate if the transmembrane potassium ion flow contributes to the adenosine-induced action in investi- gated blood vessel. This question was substantiated by earlier reports that in different animal or human blood vessels adenosine-evoked vascular responses were associated with an opening of different types of potassium ion channels. This signalling pathway re- garding the vasodilatation induced by adenosine or adenosine analogues have been, for example, de- scribed in mouse coronary vessels, porcine coronary and retinal arterioles, rat tail and renal arteries or hu- man small coronary arteries and arterioles [10, 12, 14, 15, 17, 19, 36]. This pattern of adenosine action was also detected in our study. Namely, in all investigated groups the adenosine-induced relaxation has been sig- nificantly inhibited in the presence of high K+, thus suggesting that the transduction mechanism of carotid artery response to adenosine was strongly associated with an opening of potassium ion channels located on smooth muscle cells. Still, the obtained results were not consistent in all investigated groups. Namely, in the group of non-diabetic rats an inhibition obtained in the presence of high K+was more prominent in the presence of concomitant vascular occlusion. This sug- gests that the short-term ischemia of investigated blood vessel additionally stimulated signalling me- chanism connected to the transmembrane potassium flow. In fact, it is plausible to imply that this can be an

Adenosine action on carotid artery in diabetes

Miroslav Radenkoviæ et al.

(9)

adenosine-induced relaxation by high K+was signifi- cantly less pronounced in diabetic animals not sub- jected to the vascular occlusion, if compared to the corresponding non-diabetic group of rats. This clearly suggests that diabetes-related pathological process significantly inhibited apparently very important transduction cascade of adenosine action connected to transmembrane potassium flow on smooth muscle cells. Finally, in the group of diabetic animals submit- ted to the vascular occlusion the obtained result did not differ from the one recorded in the group of non- diabetic and non-operated animals. Still, there was a similar trend of less pronounced reduction of adenosine-evoked relaxation in preparations obtained after carotid artery occlusion in diabetic animals, compared to those without induced diabetes. How- ever, this final result requires further clarification.

Conclusions

Adenosine produced an equi-effective concentration- dependent and endothelium-independent relaxation of the carotid artery irrespective of vascular occlusion or the presence of diabetes. The obtained results indicate that the pharmacological potency of adenosine has been reduced at the highest level by the simultaneous presence of diabetes and vascular occlusion. Taking into apart the endothelium-independent mechanism involved in carotid artery response to adenosine, it can be postulated that this process is related to the functional changes on smooth muscle cells. The trans- membrane potassium ion flow notably contributes to the adenosine-induced action in investigated blood vessel. In the occluded carotid arteries obtained from non-diabetic rats the input of potassium ion flow was more pronounced compared to the non-occluded vas- cular rings. On the other hand, it was shown that dia- betes solely reduced adenosine-evoked transduction cascade connected to transmembrane potassium flow.

Acknowledgments:

This work was supported by the Ministry of Education and Science – Republic of Serbia with the Grant 175073. The authors would like to thank Mrs. Spomenka Luèiæ for technical assistance.

from diabetic rats. Life Sci, 2008, 82, 279–289.

2.Abebe W, Mustafa SJ: Effect of low density lipoprotein on adenosine receptor-mediated coronary vasorelaxation in vitro. J Pharmacol Exp Ther, 1997, 282, 851–857.

3.Beernaert H, Vanherle AM, Bertrand S: Critical aspects in implementing the OECD monograph No. 14 “The ap- plication of the principles of GLP to in vitro studies”.

Ann Ist Super Sanita, 2008, 44, 348–356.

4.Cheng DY, DeWitt BJ, Suzuki F, Neely CF, Kadowitz PJ: Adenosine A1 and A2 receptors mediate tone- dependent responses in feline pulmonary vascular bed.

Am J Physiol, 1996, 270, H200–H207.

5.Chroœciñska-Krawczyk M, Jargie³³o-Baszak M, Wa³ek M, Tylus B, Czuczwar SJ. Caffeine and the anticonvul- sant potency of antiepileptic drugs: experimental and clinical data. Pharmacol Rep, 2011, 63, 12–18.

6.Conde SV, Monteiro EC: Hypoxia induces adenosine re- lease from the rat carotid body. J Neurochem, 2004, 89, 1148–1156.

7.Diniz SF, Amorim FP, Cavalcante-Neto FF, Bocca AL, Batista AC, Simm GE, Silva TA: Alloxan-induced diabe- tes delays repair in a rat model of closed tibial fracture.

Braz J Med Biol Res, 2008, 41, 373–379.

8.Fahim M, Hussain T, Mustafa SJ: Relaxation of rat aorta by adenosine in diabetes with and without hypertension:

role of endothelium. Eur J Pharmacol, 2001, 412, 51–59.

9.Festing MF, Altman DG: Guidelines for the design and statistical analysis of experiments using laboratory ani- mals. ILAR J, 2002, 43, 244–58.

10.Flood A, Headrick JP: Functional characterization of coronary vascular adenosine receptors in the mouse.

Br J Pharmacol, 2001, 133, 1063–1072.

11.Grboviæ L, Radenkoviæ M: Analysis of adenosine vascu- lar effect in isolated rat aorta: possible role of Na+/K+- ATPase. Pharmacol Toxicol, 2003, 92, 265–271.

12.Grboviæ L, Radenkoviæ M, Prostran M, Pešiæ S: Charac- terization of adenosine action in isolated rat renal artery.

Possible role of adenosine A2Areceptors. Gen Pharma- col, 2001, 35, 29–36.

13.Heaps CL, Bowles DK: Gender-specific K+-channel contribution to adenosine-induced relaxation in coronary arterioles. J Appl Physiol, 2002, 92, 550–558.

14.Heaps CL, Tharp DL, Bowles DK: Hypercholestero- lemia abolishes voltage-dependent K+channel contribu- tion to adenosine-mediated relaxation in porcine coro- nary arterioles. Am J Physiol Heart Circ Physiol, 2005, 288, H568–H576.

15.Jeppesen P, Aalkjaer C, Bek T: Adenosine relaxation in small retinal arterioles requires functional Na-K pumps and KATPchannels. Curr Eye Res, 2002, 25, 23–28.

16.Joshi S, Hartl R, Wang M, Feng L, Hoh D, Sciacca RR, Mangla S: The acute cerebrovascular effects of intraca- rotid adenosine in nonhuman primates. Anesth Analg, 2003, 97, 231–237.

17.Kêdzior K, Szczepañska R, Kociæ I: Contribution of NO, ATP-sensitive K+channels and prostaglandins to adeno-

(10)

sine receptor agonists-induced relaxation of the rat tail artery. Pharmacol Rep, 2009, 61, 330–334.

18.Keef KD, Pasco JS, Eckman DM: Purinergic relaxation and hyperpolarization in guinea pig and rabbit coronary artery: role of the endothelium. J Pharmacol Exp Ther, 1992, 260, 592–600.

19.Kemp BK, Cocks TM: Adenosine mediates relaxation of human small resistance-like coronary arteries via A2Bre- ceptors. Br J Pharmacol, 1999, 126, 1796–1800.

20.Kinoshita H, Kimoto Y, Nakahata K, Iranami H, Dojo M, Hatano Y: The role of K+channels in vasorelaxation in- duced by hypoxia and the modulator effects of lidocaine in the rat carotid artery. Anesth Analg, 2003, 97, 333–338.

21.Manjunath S, Kugali SN, Deodurg PM: Effect of clo- nidine on blood glucose levels in euglycemic and alloxan-induced diabetic rats and its interaction with glibenclamide. Indian J Pharmacol, 2009, 41, 218–220.

22.Nakagiri A, Sunamoto M, Takeuchi K, Murakami M:

Evidence for the involvement of NADPH oxidase in ischemia/reperfusion-induced gastric damage via angio- tensin II. J Physiol Pharmacol, 2010, 61, 171–179.

23.Neubig RR, Spedding M, Kenakin T, Christopoulos A:

International Union of Pharmacology Committee on Re- ceptor Nomenclature and Drug Classification. XXXVIII.

Update on terms and symbols in quantitative pharmacol- ogy. Pharmacol Rev, 2003, 55, 597–606.

24.Peart JN, Headrick JP: Adenosinergic cardioprotection:

multiple receptors, multiple pathways. Pharmacol Ther, 2007, 114, 208–221.

25.Perry P: The ethics of animal research: a UK perspec- tive. ILAR J, 2007, 48, 42–46.

26.Phillis JW: Adenosine and adenine nucleotides as regula- tors of cerebral blood flow: roles of acidosis, cell swel- ling, and KATP channels. Crit Rev Neurobiol, 2004, 16, 237–270.

27.Preet A, Gupta BL, Yadava PK, Baquer NZ: Efficacy of lower doses of vanadium in restoring altered glucose me- tabolism and antioxidant status in diabetic rat lenses.

J Biosci, 2005,30, 221–230.

28.Radenkoviæ M: The OECD principles of good laboratory practice and the current bioethics. In: Bioethics and Pharmacology: Ethics in Preclinical and Clinical Drug Development. Eds. Todoroviæ Z, Prostran M, Turza K, Transworld Research Network, India, 2012, 43–50.

29.Radenkoviæ M, Grboviæ L, Pešiæ S, Stojiæ D: Isolated rat inferior mesenteric artery response to adenosine: possi- ble participation of Na+/K+-ATPase and potassium chan- nels. Pharmacol Rep, 2005, 57, 824–832.

30.Radenkoviæ M, Stojanoviæ M, Jankoviæ R, Topaloviæ M, Stojiljkoviæ M: Combined contribution of endothelial re- laxing autacoides in the rat femoral artery response to CPCA: an adenosine A2receptor agonist. Scienti- ficWorldJournal, 2012, 2012, 143818.

doi:10.1100/2012/143818.

31.Radenkoviæ M, Topaloviæ M, Stojanoviæ M: Isolated rat femoral artery response to adenosine: involvement of po-

tassium channels. In: Inflammation, Lipids and Immuno- logic Reactions During Atherogenesis. Eds. Heinle H, Marx N, Lorkowski S, Schaefer J, Deutsche Gesellschaft fuer Arterioskleroseforschung, Tuebingen, 2010, 189–192.

32.Ralevic V, Burnstock G: Receptors for purines and py- rimidines. Pharmacol Rev, 1998, 50, 413–492.

33.Roganoviæ J, Radenkoviæ M, Stojiæ D: ACh- and VIP- induced vasorelaxation in rabbit facial artery after carotid artery occlusion. Arch Oral Biol, 2010, 55, 333–342.

34.Roganoviæ J, Radenkoviæ M, Taniæ N, Taniæ N, Petroviæ N, Stojiæ D: Impairment of acetylcholine-mediated endothelium-dependent relaxation in isolated parotid ar- tery of the alloxan-induced diabetic rabbit. Eur J Oral Sci, 2011,119, 352–360.

35.Samsel M, Dzierzbicka K. Therapeutic potential of adenosine analogues and conjugates. Pharmacol Rep, 2011, 63, 601–617.

36.Sato A, Terata K, Miura H, Toyama K, Loberiza FR Jr, Hatoum OA, Saito T et al.: Mechanism of vasodilation to adenosine in coronary arterioles from patients with heart disease. Am J Physiol Heart Circ Physiol, 2005, 288, H1633–H1640.

37.Shi Y, Ku DD, Man RY, Vanhoutte PM: Augmented endothelium-derived hyperpolarizing factor-mediated re- laxations attenuate endothelial dysfunction in femoral and mesenteric, but not in carotid arteries from type I diabetic rats. J Pharmacol Exp Ther, 2006, 318, 276–281.

38.Steinhorn RH, Morin FC 3rd, Van Wylen DG, Gugino SF, Giese EC, Russell JA: Endothelium-dependent re- laxations to adenosine in juvenile rabbit pulmonary arter- ies and veins. Am J Physiol, 1994, 266, H2001–H2006.

39.Tabrizchi R, Bedi S: Pharmacology of adenosine receptors in the vasculature. Pharmacol Ther, 2001, 91, 133–147.

40.Turlapaty PD, Lum G, Altura BM: Vascular responsive- ness and serum biochemical parameters in alloxan diabe- tes mellitus. Am J Physiol, 1980, 239, E412–E421.

41.van den Oever IA, Raterman HG, Nurmohamed MT, Simsek S: Endothelial dysfunction, inflammation, and apoptosis in diabetes mellitus. Mediators Inflamm, 2010, 2010, 792393.

42.Wigg SJ, Tare M, Tonta MA, O’Brien RC, Meredith IT, Parkington HC: Comparison of effects of diabetes melli- tus on an EDHF-dependent and an EDHF-independent artery. Am J Physiol Heart Circ Physiol, 2001, 281, H232–H240.

43.Yousif MH, Benter IF, Akhtar S: The role of tyrosine kinase-mediated pathways in diabetes-induced altera- tions in responsiveness of rat carotid artery. Auton Auta- coid Pharmacol, 2005, 25, 69–78.

Received: July 25, 2012; in the revised form: January 3, 2013;

accepted: January 11, 2013.

Adenosine action on carotid artery in diabetes

Miroslav Radenkoviæ et al.

Cytaty

Powiązane dokumenty

Background and aim: We aimed to investigate the role of the Duke treadmill score (DTS) in predicting the presence and severity of coronary artery disease (CAD) by using the

Despite a large increase in the interest in mechanical properties of the arteries, invasive measurements of arterial stiffness, and Doppler measurements of vascular resistance,

Prevalence of increased platelet reactivity despite ASA treatment (ASA resistance) in patients treated surgically for carotid artery disease is high, suggesting a possibility

Probability of survival free from death, myocardial infarction (MI), and stroke/transient ischa- emic attack in patients undergoing carotid artery stenting, stratified by the

We present a case of an asymptomatic migration of a bare metal stent (BMS) from the left main coronary artery (LMCA) to the right internal carotid artery (RICA), treated with

Ze względu na obecność krytycznego zwężenia w rozgałęzieniu tętnicy szyjnej wspólnej lewej i proksymalnym segmencie tętnicy szyjnej wewnętrznej lewej pacjentkę zakwalifikowano

Thickening of the intima-media complex of femoral arteries is an independent risk factor for one-vessel CAD development while presence of atherosclerotic lesions in the common

Wykazanie zmian miażdżyco- wych w tętnicach szyjnych w tej grupie chorych automa- tycznie przenosi ich do grupy wyższego ryzyka, niż by to wynikało ze skali Framingham, w której